Eicosapentaenoic acid inhibits voltage‐gated sodium channels and invasiveness in prostate cancer cells

Article date: February 2009

By: T Nakajima, N Kubota, T Tsutsumi, A Oguri, H Imuta, T Jo, H Oonuma, M Soma, K Meguro, H Takano, T Nagase, T Nagata in Volume 156, Issue 3, pages 420-431

Background and purpose:  The voltage‐gated Na+ channels (Nav) and their corresponding current (INa) are involved in several cellular processes, crucial to metastasis of cancer cells. We investigated the effects of eicosapentaenoic (EPA), an omega‐3 polyunsaturated fatty acid, on INa and metastatic functions (cell proliferation, endocytosis and invasion) in human and rat prostate cancer cell lines (PC‐3 and Mat‐LyLu cells).

Experimental approach:  The whole‐cell voltage clamp technique and conventional/quantitative real‐time reverse transcriptase polymerase chain reaction analysis were used. The presence of Nav proteins was shown by immunohistochemical methods. Alterations in the fatty acid composition of phospholipids after treatment with EPA and metastatic functions were also examined.

Key results:  A transient inward Na+ current (INa), highly sensitive to tetrodotoxin, and NaV proteins were found in these cells. Expression of NaV1.6 and NaV1.7 transcripts (SCN8A and SCN9A) was predominant in PC‐3 cells, while NaV1.7 transcript (SCN9A) was the major component in Mat‐LyLu cells. Tetrodotoxin or synthetic small interfering RNA targeted for SCN8A and SCN9A inhibited metastatic functions (endocytosis and invasion), but failed to inhibit proliferation in PC‐3 cells. Exposure to EPA produced a rapid and concentration‐dependent suppression of INa. In cells chronically treated (up to 72h) with EPA, the EPA content of cell lipids increased time‐dependently, while arachidonic acid content decreased. Treatment of PC‐3 cells with EPA decreased levels of mRNA for SCN9A and SCN8A, cell proliferation, invasion and endocytosis.

Conclusion and implications:  Treatment with EPA inhibited INa directly and also indirectly, by down‐regulation of Nav mRNA expression in prostate cancer cells, thus inhibiting their metastatic potential.

Mandarin translation of abstract

DOI: 10.1111/j.1476-5381.2008.00059.x

View this article